Skip to Content

PharmChem Inc PCHM

Morningstar Rating
$3.45 −0.05 (1.43%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

PCHM is trading within a range we consider fairly valued.
Price
$3.47
Fair Value
$3.32
Uncertainty
Extreme
1-Star Price
$13.48
5-Star Price
$5.62
Economic Moat
Lxmj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PCHM is a good fit for your portfolio.

Trading Information

Previous Close Price
$3.50
Day Range
$3.453.45
52-Week Range
$2.104.00
Bid/Ask
$3.14 / $3.57
Market Cap
$16.03 Mil
Volume/Avg
1,400 / 2,765

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

PharmChem Inc is engaged in selling and distributing of the PharmChek Sweat Patch Device. PharmChek is a system that uses sweat to detect the presence of illegal drugs. It consists of a transparent polyurethane outer covering, a small absorbent pad, and a release liner. The Company's customers include federal, state, and local governments, state and local drug courts, as well as independent companies which provide drug rehabilitation and other related services. Geographically the activities are carried out throughout the United States.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
170

Valuation

Metric
PCHM
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
PCHM
Quick Ratio
1.01
Current Ratio
1.23
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
PCHM
Return on Assets (Normalized)
−9.49%
Return on Equity (Normalized)
−20.54%
Return on Invested Capital (Normalized)
−12.71%
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
NltjbkkrgGxvwfrb$183.1 Bil
Stryker Corp
SYK
HvhzhvsgtqWyxd$126.3 Bil
Boston Scientific Corp
BSX
HbrzpgfxsZpcmkl$110.1 Bil
Medtronic PLC
MDT
CwgfblcqHjlqy$100.9 Bil
Edwards Lifesciences Corp
EW
DtdlmznrmJqrkwk$37.6 Bil
DexCom Inc
DXCM
KpbvhkbzbNfyl$25.6 Bil
Koninklijke Philips NV ADR
PHG
JxhkxhxHmqfb$24.1 Bil
Steris PLC
STE
PhbptrdjKyyqqr$23.0 Bil
Zimmer Biomet Holdings Inc
ZBH
HlvltxylMkyjy$22.9 Bil
Align Technology Inc
ALGN
KvqjystfPrmnn$16.6 Bil

Sponsor Center